The development of peptide-drug conjugates (PDCs) strategies for paclitaxel
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Drug Delivery"
DOI: 10.1080/17425247.2022.2039621
Abstract: ABSTRACT Introduction Paclitaxel is a powerful and effective anti-tumor drug with wide clinical application. However, there are still some limitations, including poor water solubility, low specificity, and susceptibility to drug resistance. The peptide-drug conjugates (PDCs)… read more here.
Keywords: conjugates pdcs; drug conjugates; paclitaxel; drug ... See more keywords